2D solid-state NMR analysis of inclusion in drug-cyclodextrin complexes

Molecular Pharmaceutics

Volumn 9, Issue 11, 2012, Pages 3357-3374

  Vogt, Frederick G ^a   Strohmeier, Mark ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

2D solid state NMR; cyclodextrin complex; dipolar coupling; inclusion; spin diffusion

Indexed keywords

ADEFOVIR DIPIVOXIL; ALPHA CYCLODEXTRIN; BETA CYCLODEXTRIN; BETA CYCLODEXTRIN SULFOBUTYL ETHER; CARBON 13; CYCLODEXTRIN; CYCLODEXTRIN DERIVATIVE; DEXAMETHASONE; DIFLUNISAL; DRUG; FLUORINE; HYDROGEN; PHOSPHORUS 31; PREDNISOLONE; VORICONAZOLE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DETERMINATION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; FLUORINE NUCLEAR MAGNETIC RESONANCE; FRACTIONATION; HETERONUCLEAR NUCLEAR MAGNETIC RESONANCE; MOLECULAR PROBE; MOLECULE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; SOLID STATE; SOLID STATE NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SUBSTITUTION REACTION;

ADENINE; CARBON RADIOISOTOPES; CYCLODEXTRINS; DIFLUNISAL; FLUORINE RADIOISOTOPES; HYDROGEN; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; ORGANOPHOSPHONATES; PHOSPHORUS; PYRIMIDINES; TRIAZOLES;

EID: 84868563783     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300416w     Document Type: Article

References (69)

1. Loftsson, T.; Jarho, P.; Masson, M.; Jaervinen, T. Cyclodextrins in drug delivery Expert Opin. Drug Delivery 2005, 2, 335-351
2. Loftsson, T.; Vogensen, S. B.; Brewster, M. E.; Konraosdottir, F. Effects of cyclodextrins on drug delivery through biological membranes J. Pharm. Sci. 2007, 96, 2532-2546
3. Stella, V. J.; Rajewski, R. A. Cyclodextrins: their future in drug formulation and delivery Pharm. Res. 1997, 14, 556-567
4. Rajewski, R. A.; Stella, V. J. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery J. Pharm. Sci. 1996, 85, 1142-1169
5. Uekama, K. Design and evaluation of cyclodextrin-based drug formulation Chem. Pharm. Bull. 2004, 52, 900-915
6. Challa, R.; Ahuja, A.; Ali, J.; Khar, R. K. Cyclodextrins in drug delivery: An updated review AAPS PharmSciTech 2005, 6, E329-E357
7. Dutet, J.; Lahiani-Skiba, M.; Didier, L.; Jezequel, S.; Bounoure, F.; Barbot, C.; Arnaud, P.; Skiba, M. Nimesulide/cyclodextrin/PEG 6000 ternary complexes: physico-chemical characterization, dissolution studies and bioavailability in rats J. Inclusion Phenom. Macrocyclic Chem. 2007, 57, 203-209
8. Alexanian, C.; Papademou, H.; Vertzoni, M.; Archontaki, H.; Valsami, G. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of β-cyclodextrin derivatives J. Pharm. Pharmacol. 2008, 60, 1433-1439
9. Sauceau, M.; Rodier, E.; Fages, J. Preparation of inclusion complex of piroxicam with cyclodextrin by using supercritical carbon dioxide J. Supercrit. Fluids 2008, 47, 326-332
10. Hussein, K.; Türk, M.; Wahl, M. A. Drug loading into β-cyclodextrin granules using a supercritical fluid process for improved drug dissolution Eur. J. Pharm. Sci. 2008, 33, 306-312
11. Pighi, R.; Fjordgaard Andersen, S. A process for the preparation of a piroxicam-β-cyclodextrin inclusion compound. PCT Int. Appl. WO 2006013039 A2 20060209, 2006; 23 pp.
12. Capocchi, A. A process for the preparation of piroxicam-β- cyclodextrin inclusion compounds. PCT Int. Appl. WO 2003105906 A1 20031224, 2003; 19 pp.
13. Jiang, J.; Zhou, J.; Li, Y. Method for preparing microcapsule of piroxicam-β-cyclodextrin inclusion compound by spray coating. Faming Zhuanli Shenqing Gongkai Shuomingshu. CN 101491529 A 20090729, 2009; 9 pp.
14. Benkirane-Jessel, N.; Schwinte, P.; Falvey, P.; Darcy, R.; Haikel, Y.; Schaaf, P.; Voegel, J.-C.; Ogier, J. Build-up of polypeptide multilayer coatings with anti-inflammatory properties based on the embedding of piroxicam-cyclodextrin complexes Adv. Funct. Mater. 2004, 14, 174-182
15. Stella, V. J.; He, Q. Cyclodextrins Toxicol. Pathol. 2008, 36, 30-42
16. Luke, D. R.; Tomaszewski, K.; Damle, B.; Schlamm, H. T. Review of the basic and clinical pharmacology of sulfobutylether-β-cyclodextrin (SBECD) J. Pharm. Sci. 2010, 99, 3291-3301
17. Wulff, M.; Aldén, M.; Tegenfeldt, J. Solid-state NMR investigation of indomethacin-cyclodextrin complexes in PEG 6000 carrier Bioconjugate Chem. 2002, 13, 240-248
18. Mura, P.; Faucci, M. T.; Bettinetti, G. P. The influence of polyvinylpyrrolidone on naproxen complaxation with hydroxypropyl-β- cyclodextrin Eur. J. Pharm. Sci. 2001, 13, 187-194
19. El-Maradny, H. A.; Mortada, S. A.; Kamel, O. A.; Hikal, A. H. Characterization of ternary complexes of meloxicam-HPβCD and PVP or L-arginine prepared by the spray-drying technique Acta Pharm. 2008, 58, 455-466
20. Lincoln, S. F.; Coates, J. H.; Doddridge, B. G.; Hounslow, A. M. The inclusion of the drug diflunisal by α- and β-cyclodextrins. A nuclear magnetic resonance and ultraviolet spectroscopic study J. Inclusion Phenom. 1987, 5, 49-53
21. Lincoln, S. F.; Hounslow, A. M.; Coates, J. H.; Doddridge, B. G. The inclusion of diflunisal by α- and β-cyclodextrins: A fluorine-19 nuclear magnetic resonance and spectrophotometric study J. Chem. Soc., Faraday Trans. 1 1987, 83, 2697-2703
22. Zornoza, A.; Sanchez, M.; Velaz, I.; Fernandez, L. Diflunisal and its complexation with cyclodextrins. A fluorimetric study Biomed. Chromatogr. 1999, 13, 111-112
23. Chowdary, K. P. R.; Nalluri, B. N. Nimesulide and beta-cyclodextrin inclusion complexes: physicochemical characterization and dissolution rate studies Drug Dev. Ind. Pharm. 2000, 26, 1217-1220
24. Redenti, E.; Peveri, T.; Zanol, M.; Ventura, P.; Gnappi, G.; Montenero, A. A study on the differentiation between amorphous piroxicam:β- cyclodextrin complex and a mixture of the two amorphous components Int. J. Pharm. 1996, 129, 289-294
25. Van Hees, T.; Piel, G.; De Hassonville, S. H.; Evrad, B.; Delattre, L. Determination of the free/included piroxicam ratio in cyclodextrin complexes: comparison between UV spectrophotometry and differential scanning calorimetry Eur. J. Pharm. Sci. 2002, 15, 347-353
26. Sotthivirat, S.; Lubach, J. W.; Haslam, J. L.; Munson, E. J.; Stella, V. J. Characterization of prednisolone in controlled porosity osmotic pump pellets using solid-state NMR spectroscopy J. Pharm. Sci. 2007, 96, 1008-1017
27. 13C nuclear magnetic resonance spectroscopic study on amorphous solid complexes of tolbutamide with 2-hydroxypropyl-α- and -β- cyclodextrins Pharm. Res. 1999, 16, 1729-1734
28. Potrzebowski, M. J.; Kazmierski, S. High-resolution solid-state NMR studies of inclusion complexes Top. Curr. Chem. 2005, 246, 91-140
29. Chierotti, M. R.; Gobetto, R. Solid-state NMR studies of weak interactions in supramolecular systems Chem. Commun. 2008, 14, 1621-1634
30. Higashi, K.; Ideura, S.; Waraya, H.; Moribe, K.; Yamamoto, K. Incorporation of salicylic acid molecules into the intermolecular spaces of γ-cyclodextrin-polypseudorotaxane Cryst. Growth Des. 2009, 9, 4243-4246
31. 13C-NMR investigation of the structure of the 1:1 amorphous piroxicam:β-cyclodextrin inclusion compound Biospectroscopy 1999, 5, 243-251
32. Morales, A.; Struppe, J.; Melendez, E. Host-guest interactions between niobocene dichloride and α-, β-, and γ-cyclodextrins: preparation and characterization J. Inclusion Phenom. Macrocyclic Chem. 2008, 60, 263-270
33. 1H heteronuclear correlation NMR spectroscopic studies for the inclusion complex of cyclomaltoheptaose (β-cyclodextrin) with a new Helicobacter pylori eradicating agent (TG44) in the amorphous state Carbohydr. Res. 2006, 341, 499-506
34. Meier, B. H. Polarization transfer and spin diffusion in solid-state NMR Adv. Magn. Opt. Reson. 1994, 18, 1-116
35. Cheung, T. T. P. Spin diffusion in solids. In The Encyclopedia of NMR; Harris, R. K.; Grant, D. M., Eds.; Wiley: New York, 1996; pp 4518-4524.
36. 1 relaxation measurements Mol. Pharmaceutics 2010, 7, 1667-1691
37. Patel, J. R.; Carlton, R. A.; Yuniatine, F.; Needham, T. E.; Wu, L.; Vogt, F. G. Preparation and structural characterization of amorphous spray-dried dispersions of tenoxicam with enhanced solubility J. Pharm. Sci. 2012, 101, 641-663
38. Vogt, F. G.; Clawson, J. S.; Strohmeier, M.; Edwards, A. J.; Pham, T. N.; Watson, S. A. Solid-state NMR analysis of organic cocrystals and complexes Cryst. Growth Des. 2009, 9, 921-937
39. Vogt, F. G.; Vena, J. A.; Chavda, M.; Clawson, J. S.; Strohmeier, M.; Barnett, M. E. Structural analysis of 5-fluorouracil and thymine solid solutions J. Mol. Struct. 2009, 932, 16-30
40. 19F CP/MAS NMR spectroscopy Polymer 2008, 49, 2709-2716
41. Sideris, E. E.; Koupparis, M. A.; Macheras, P. E. Effect of cyclodextrins on protein binding of drugs: the diflunisal/hydroxypropyl β-cyclodextrin model case Pharm. Res. 1994, 11, 90-95
42. 1H solid-state NMR spectroscopy with DUMBO dipolar decoupling under ultra-fast MAS Chem. Phys. Lett. 2009, 469, 336-341
43. Madhu, P. K. High-resolution solid-state NMR spectroscopy of protons with homonuclear dipolar decoupling schemes under magic-angle spinning Solid State Nucl. Magn. Reson. 2009, 35, 2-11
44. Metz, G.; Wu, X.; Smith, S. O. Ramped-amplitude cross-polarization in magic-angle spinning NMR J. Magn. Reson. A 1994, 110, 219-227
45. Antzutkin, O. N. Sideband manipulation in magic-angle spinning NMR Prog. NMR Spectrosc. 1999, 35, 203-266
46. Fung, B. M.; Khitrin, A. K.; Ermolaev, K. An improved broadband decoupling sequence for liquid crystals and powders J. Magn. Reson. 2000, 142, 97-101
47. Hodgkinson, P. Heteronuclear decoupling in the NMR of solids Prog. NMR Spectrosc. 2005, 46, 197-222
48. Opella, S. J.; Frey, M. H. Selection of non-protonated carbon resonances in solid-state NMR J. Am. Chem. Soc. 1979, 101, 5854-5856
49. 13C chemical shifts in solids J. Magn. Reson. 1982, 48, 35-54
50. Harris, R. K.; Becker, E. D.; Cabral de Menezes, S. M.; Goodfellow, R.; Granger, P. NMR nomenclature. Nuclear spin properties and conventions for chemical shifts (IUPAC recommendations 2001) Pure Appl. Chem. 2001, 73, 1795-1818
51. Bevington, P. R.; Robinson, D. K. Data reduction and error analysis for the physical sciences, 3 rd ed.; McGraw-Hill: New York, 2003; pp 142-163.
52. Ernst, R. R.; Bodenhausen, G.; Wokaun, A. Principles of Nuclear Magnetic Resonance in One and Two Dimensions; Oxford University Press: New York, 1987; pp 535-538.
53. Caravatti, P.; Deli, J. A.; Bodenhausen, G.; Ernst, R. R. Direct evidence of microscopic homogeneity in disordered solids J. Am. Chem. Soc. 1982, 104, 5506-5507
54. 13C NMR heteronuclear dipolar-correlation spectroscopy of solids with frequency-switched Lee-Goldburg homonuclear decoupling J. Magn. Reson. 1997, 124, 516-519
55. 13C) distances in high speed MAS NMR J. Am. Chem. Soc. 2000, 122, 3465-3472
56. Vogt, F. G.; Williams, G. R. Analysis of a nanocrystalline polymer dispersion of ebselen using solid-state NMR, Raman microscopy, and X-ray diffraction Pharm. Res. 2012, 29, 1866-1881
57. 1H spin diffusion from lipids using solid-state NMR spectroscopy J. Am. Chem. Soc. 2002, 124, 874-883
58. Pawley, G. S. Unit-cell refinement from powder diffraction scans J. Appl. Crystallogr. 1981, 14, 357-361
59. Cross, W. I.; Blagden, N.; Davey, R. J.; Pritchard, R. G.; Neumann, M. A.; Roberts, R. J.; Rowe, R. C. A whole output strategy for polymorph screening: Combining crystal structure prediction, graph set analysis, and targeted crystallization experiments in the case of diflunisal Cryst. Growth Des. 2003, 3, 151-158
60. Ravikumar, K.; Sridhar, B.; Prasad, K. D.; Rao, A. K. S. B. Voriconazole, an antifungal drug Acta Crystallogr., E 2007, 63, o565-o567
61. 5) Cryst. Struct. Commun. 1977, 6, 123-126
62. Suitchmezian, V.; Jess, I.; Sehnert, J.; Seyfarth, L.; Senker, J.; Nather, C. Structural, thermodynamic, and kinetic aspects of the polymorphism and pseudopolymorphism of prednisolone (11,17α,21-trihydroxy-1,4- pregnadien-3,20-dion) Cryst. Growth Des. 2008, 8, 98-107
63. Arimilli, M. N.; Kelly, D. E.; Lee, T. T. K.; Manes, L. V.; Munger, J. D.; Prisbe, E. J.; Schultze, L. M. Nucleotide analog compositions. U. S. Patent 6,451,340, 2002.
64. McCusker, L. B.; von Dreele, R. B.; Cox, D. E.; Louër, D.; Scardi, P. Rietveld refinement guidelines J. Appl. Crystallogr. 1999, 32, 36-50
65. Baldinozzi, J.; Berar, J. F. Modeling of line-shape asymmetry in powder diffraction J. Appl. Crystallogr. 1993, 26, 128-129
66. 19F-NMR as a tool for investigation of drug-cyclodextrin complexes Drug. Dev. Ind. Pharm. 2003, 29, 107-112
67. 13C CP/MAS NMR spectroscopy and direct exponential curve resolution algorithm J. Am. Chem. Soc. 1999, 121, 11554-11557
68. Martre, A. M.; Mousset, G.; Pouillen, P. Cyclodextrin host-guest complexes. Electrochemical characterization of a specific interaction with α-CD J. Electroanal. Chem. 1990, 281, 279-282
69. Perlovich, G. L.; Hansen, L. K.; Bauer-Brandl, A. Interrelation between thermochemical and structural data of polymorphs exemplified by diflunisal J. Pharm. Sci. 2002, 91, 1036-1045